Jeff Welch PhD
Director of New Ventures
Jeff Welch joined OTC as Director of New Ventures in early 2021 after five years as Bioventus’ executive responsible for all corporate development activities.
Jeff’s previous experiences include time with Bioventus, Smith and Nephew, Nanosyn, and Square 1 Bank, where he has participated in the development, financing, licensing, acquisition, and commercialization of innovative new technologies in multiple life science and healthcare fields.
He is passionate about new technology development and maximizing the odds new products will achieve their potential to improve human life through business success.
Jeff received his PhD in Neurobiology from Duke University School of Medicine and his BS degree in Economics and Biology from Duke University.